Biomarkers for predicting tumor response to PD-1 inhibitors in patients with advanced pancreatic cancer

• Asıl Yazarlar: Xin Qiu (Yazar), Zhan Shi (Yazar), Fan Tong (Yazar), Changchang Lu (Yazar), Yahui Zhu (Yazar), Qiaoli Wang (Yazar), Qing Gu (Yazar), Xiaoping Qian (Yazar), Fanyan Meng (Yazar), Baorui Liu (Yazar), Juan Du (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Taylor & Francis Group, 2023-01-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Pancreatic cancer is among the most lethal malignant neoplasms, and few patients with pancreatic cancer benefit from immunotherapy. We retrospectively analyzed advanced pancreatic cancer patients who received PD-1 inhibitor-based combination therapies during 2019-2021 in our institution. The clinica...